Prostate cancer remains the most common malignancy among U.S. men, and internationally it ranks fourth. Though few studies have offered much insight into what triggers this disease, a growing number ...

Follow-up overall survival, months, median (range) 96 (15-120) Follow-up PSA to recurrence or death, months, median (range) 55 (11-111) Follow-up PSA patients alive and recurrence-free, months, median ...

A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...

Last week, Joe Biden was diagnosed with an "aggressive" form of prostate cancer — one that has metastasized to his bones. The discovery of a prostate nodule was made after he sought medical care for ...

Please provide your email address to receive an email when new articles are posted on . Primary care providers frequently order prostate cancer screenings for older patients, even when they provide ...

A new study by researchers at the Johns Hopkins University has found that second opinions did not change treatment choice among men diagnosed with low-risk prostate cancer. Men often seek second ...

Prostate cancer is a common cancer in men that, once it progresses to the later stages, has serious morbidity and mortality consequences as well as burdensome financial issues for patients, the ...

Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society. But guidelines for prostate cancer ...

At a minimum, the value framework assessment reminds us that there is considerable cost to both patients and society for more effective treatment. Oncologists should include cost in the overall ...